Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06172790
What this trial is testing

The Effects of the Otago Exercise Program

Who this might be right for
Pulmonary Arterial HypertensionHeart Defects, Congenital
Istanbul University - Cerrahpasa 50
Testing effectiveness (Phase 2)Study completedNCT02279160
What this trial is testing

Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 61
Testing effectiveness (Phase 2)Study completedNCT00615823
What this trial is testing

Atorvastatin in Pulmonary Hypertension

Who this might be right for
Hypertension, Pulmonary
Chinese Academy of Medical Sciences, Fuwai Hospital 220
Not applicableStudy completedNCT05242380
What this trial is testing

Exercise Training in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Saglik Bilimleri Universitesi 32
Testing effectiveness (Phase 2)Study completedNCT00781885
What this trial is testing

A Multi-Center, Open-Label, Multiple Dose, Dose Finding Study Exploring the Safety and Tolerability of Beraprost Sodium Modified Release in PAH Patients

Who this might be right for
Pulmonary Arterial Hypertension
Lung Biotechnology PBC 19
Not applicableEnrolling By InvitationNCT03388476
What this trial is testing

Endtidal Carbon Dioxide for Earlier Detection of Pulmonary Hypertension

Who this might be right for
Hypertension, PulmonaryHypertension;Pulmonary;PrimaryChronic Thromboembolic Pulmonary Hypertension+2 more
University of Giessen 500
Not applicableUnknownNCT04732650
What this trial is testing

Real World Difference After Changing Medication From Nonselective to Selective Endothelin Receptor Antagonist in Stable Eisenmenger Syndrome

Who this might be right for
Eisenmenger Complex
Samsung Medical Center 40
Large-scale testing (Phase 3)Looking for participantsNCT07824674
What this trial is testing

The Effect of Additive On-Demand Sildenafil vs. Dextrose Candy on Maximum Exercise Capacity in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)
Silvia Ulrich 20
Not applicableStudy completedNCT00641836
What this trial is testing

Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension

Who this might be right for
Idiopathic Pulmonary Arterial Hypertension
Zhejiang University 98
Post-approval studies (Phase 4)UnknownNCT03053739
What this trial is testing

To Compare the Efficacy of Combination Therapy vs Monotherapy for Pulmonary Arterial Hypertension in Systemic Sclerosis

Who this might be right for
Associated Pulmonary Arterial Hypertension
Post Graduate Institute of Medical Education and Research, Chandigarh 50
Testing effectiveness (Phase 2)Ended earlyNCT05135000
What this trial is testing

Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Novartis Pharmaceuticals 47
Not applicableStudy completedNCT01572077
What this trial is testing

Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Ottawa Heart Institute Research Corporation 20
Early research (Phase 1)Looking for participantsNCT06429930
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of L608 in Healthy Adults

Who this might be right for
Healthy Adult Participants
Pharmosa Biopharm Inc. 40
Large-scale testing (Phase 3)Study completedNCT01560637
What this trial is testing

An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 471
Not applicableStudy completedNCT04663230
What this trial is testing

Right Atrial Fibrosis in Pulmonary Hypertension

Who this might be right for
Pulmonary HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Arterial Hypertension
University of Giessen 40
Early research (Phase 1)WithdrawnNCT05731492
What this trial is testing

Macitentan in Children Below 2 Years of Age

Who this might be right for
Arterial Hypertension, Pulmonary
Actelion
Not applicableStudy completedNCT02267200
What this trial is testing

The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD

Who this might be right for
Hypertension,Pulmonary
Shanghai Jiao Tong University School of Medicine 30
Not applicableLooking for participantsNCT04278404
What this trial is testing

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Who this might be right for
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22 more
Duke University 5,000
Not applicableEnded earlyNCT01319045
What this trial is testing

Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease

Who this might be right for
Pulmonary Arterial HypertensionCongenital Heart DiseaseEisenmenger's Syndrome
University of California, Los Angeles 5
Early research (Phase 1)Ended earlyNCT04991194
What this trial is testing

Effect of Age-gender on the Pharmacokinetic and Pharmacodynamic Profiles of BIA 5 1058

Who this might be right for
Pulmonary Arterial Hypertension
Bial - Portela C S.A. 61
Next Page